日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota

一项关于阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌疗效与肠道菌群关联性的研究

期刊:Journal of General Internal Medicine
影响因子:4.2
doi:10.1007/s11606-026-10261-5
Rivera, Kevin J; Tanaka, Yusuke; Miki, Daiki; Hayes, C Nelson; Kawahara, Michihiko; Sueda, Saki; Emori, Tomoaki; Hashimoto, Kou; Mitamura, Yuri; Tanaka, Aiko; Hiraoka, Keiichi; Johira, Yusuke; Miura, Ryoichi; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Kawaoka, Tomokazu; Tsuge, Masataka; Oka, Shiro
微生物学
细胞生物学
肠道菌群
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study

阿特珠单抗联合贝伐珠单抗经导管动脉化疗栓塞术（三明治策略）与阿特珠单抗单药联合贝伐珠单抗治疗肝细胞癌的疗效比较：一项多中心回顾性研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000549979
Hashimoto, Ko; Kawaoka, Tomokazu; Emori, Tomoaki; Tanaka, Aiko; Shirane, Yuki; Miura, Ryoichi; Fujii, Yasutoshi; Nakahara, Hikaru; Yamaoka, Kenji; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Miki, Daiki; Hayes, C Nelson; Hiramatsu, Akira; Amioka, Kei; Nonaka, Michihiro; Aisaka, Yasuyuki; Morio, Kei; Moriya, Takashi; Teraoka, Yuji; Kono, Hirotaka; Suehiro, Yosuke; Masaki, Keiichi; Ohya, Kazuki; Takaki, Shintaro; Mori, Nami; Tsuji, Keiji; Kosaka, Yumi; Nakahara, Takashi; Aikata, Hiroshi; Tsuge, Masataka; Oka, Shiro
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

血清IL-6浓度是预测阿特珠单抗联合贝伐珠单抗治疗肝细胞癌患者疗效的有效生物标志物。

期刊:Journal of Gastroenterology
影响因子:5.5
doi:10.1007/s00535-024-02185-w
Miura, Ryoichi; Ono, Atsushi; Nakahara, Hikaru; Shirane, Yuki; Yamaoka, Kenji; Fujii, Yasutoshi; Uchikawa, Shinsuke; Fujino, Hatsue; Murakami, Eisuke; Kawaoka, Tomokazu; Miki, Daiki; Tsuge, Masataka; Kishi, Takeshi; Ohishi, Waka; Sakamoto, Naoya; Arihiro, Koji; Hayes, Clair Nelson; Oka, Shiro
细胞生物学
肿瘤
IL-6
肿瘤免疫
发表日期：2025
文献求助 收藏

Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B

血清HBV RNA水平在预测慢性乙型肝炎患者对恩替卡韦治疗的抗病毒反应中的应用价值

期刊:Journal of Gastroenterology
影响因子:5.5
doi:10.1007/s00535-025-02211-5
Kosaka, Masanari; Fujino, Hatsue; Tsuge, Masataka; Yamaoka, Kenji; Fujii, Yasutoshi; Uchikawa, Shinsuke; Ono, Atsushi; Murakami, Eisuke; Kawaoka, Tomokazu; Miki, Daiki; Hayes, Clair Nelson; Kashiyama, Seiya; Mokuda, Sho; Yamazaki, Shinichi; Oka, Shiro
微生物学
肝炎
发表日期：2025
文献求助 收藏

Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients

代谢功能障碍相关的脂肪肝疾病会影响慢性丙型肝炎患者持续病毒学应答后肝细胞癌的发生发展。

期刊:Journal of Gastroenterology
影响因子:5.5
doi:10.1007/s00535-025-02270-8
Yamasaki, Shintaro; Nakahara, Takashi; Tsuge, Masataka; Yamaoka, Kenji; Fujii, Yasutoshi; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Kawaoka, Tomokazu; Miki, Daiki; Oka, Shiro
肿瘤
肿瘤免疫
代谢
微生物学
脂肪肝
细胞生物学
肝炎
发表日期：2025
文献求助 收藏

Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B Patients

慢性乙型肝炎患者核苷/核苷酸类似物治疗期间血清HBV RNA检测的实用性

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms262010141
Hiraoka, Keiichi; Tsuge, Masataka; Kawahara, Michihiko; Fujino, Hatsue; Fujii, Yasutoshi; Ono, Atsushi; Murakami, Eisuke; Kawaoka, Tomokazu; Miki, Daiki; Hayes, C Nelson; Kashiyama, Seiya; Mokuda, Sho; Yamazaki, Shinichi; Oka, Shiro
肝炎
发表日期：2025
文献求助 收藏

Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development

肝脏分子失调导致非病毒相关肝细胞癌发生的多组学分析

期刊:Journal of Proteome Research
影响因子:3.6
doi:10.1021/acs.jproteome.4c00729
Nakahara, Hikaru; Ono, Atsushi; Hayes, C Nelson; Shirane, Yuki; Miura, Ryoichi; Fujii, Yasutoshi; Tamura, Yosuke; Uchikawa, Shinsuke; Fujino, Hatsue; Nakahara, Takashi; Murakami, Eisuke; Yamauchi, Masami; Kawaoka, Tomokazu; Miki, Daiki; Tsuge, Masataka; Kobayashi, Tsuyoshi; Ohdan, Hideki; Arihiro, Koji; Oka, Shiro
微生物学
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

First-Line Durvalumab plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice

真实世界临床实践中，一线度伐利尤单抗联合曲美利木单抗治疗不可切除肝细胞癌

期刊:Oncology
影响因子:1.8
doi:10.1159/000542517
Fujii, Yasutoshi; Kawaoka, Tomokazu; Shirane, Yuki; Miura, Ryoichi; Nakahara, Hikaru; Yamaoka, Kenji; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Miki, Daiki; Hayes, Nelson Clair; Tsuge, Masataka; Nakamura, Yuko; Awai, Kazuo; Oka, Shiro
肿瘤免疫
细胞生物学
肿瘤
发表日期：2025
文献求助 收藏

Analysis of the treatment outcome of duodenal varices: A retrospective case series of 15 patients from a single institution

十二指肠静脉曲张治疗效果分析：一项来自单一机构的15例患者的回顾性病例系列研究

期刊:DEN Open
影响因子:1.5
doi:10.1002/deo2.70119
Mitamura, Yuri; Murakami, Eisuke; Hashimoto, Ko; Emori, Tomoaki; Tanaka, Aiko; Tanaka, Yusuke; Hiraoka, Keiichi; Shirane, Yuki; Kosaka, Masanari; Johira, Yusuke; Miura, Ryoichi; Murakami, Serami; Yamaoka, Kenji; Fujii, Yasutoshi; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Kawaoka, Tomokazu; Miki, Daiki; Hayes, Clair Nelson; Tsuge, Masataka; Chosa, Keigo; Awai, Kazuo; Oka, Shiro
发表日期：2025
文献求助 收藏

A case of complete response to radiotherapy combined with durvalumab and tremelimumab in a patient with unknown primary hepatocellular carcinoma arising in the lumbar spine

一例腰椎原发性肝细胞癌患者，经放射治疗联合度伐利尤单抗和曲美利单抗治疗后获得完全缓解的病例报告

期刊:Clinical Journal of Gastroenterology
影响因子:0.9
doi:10.1007/s12328-024-02044-4
Tanaka, Aiko; Kawaoka, Tomokazu; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Hayes, Clair Nelson; Miki, Daiki; Tsuge, Masataka; Oka, Shiro
肿瘤免疫
细胞生物学
肿瘤
发表日期：2025
文献求助 收藏